Sjogren autoantibodies modify neonatal cardiac function via M1 muscarinic acetylcholine receptor activation

International Journal of Cardiology

Volumn 70, Issue 1, 1999, Pages 23-32

  Borda, Enri ^a   Perez Leiros, Claudia ^a   Bacman, Sandra ^a   Berra, Alejandro ^a   Sterin Borda, Leonor ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Congenital heart block; Human M1 muscarinic acetylcholine receptor peptide; Indirect immunofluorescence; M1 muscarinic acetylcholine receptor autoantibodies; Neonatal heart contractility; Nitric oxide synthase activity; Phosphoinositide turnover; Primary Sjogren syndrome

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN G; MUSCARINIC M1 RECEPTOR; NITRIC OXIDE SYNTHASE; PHOSPHATIDYLINOSITIDE; PHOSPHOLIPASE C; CYCLIC GMP; INOSITOL PHOSPHATE; MUSCARINIC RECEPTOR;

ADULT; ANIMAL TISSUE; ANTIGEN ANTIBODY REACTION; ARTICLE; CLINICAL ARTICLE; CONGENITAL HEART BLOCK; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVATION; FEMALE; HEART FUNCTION; HEART MUSCLE CONTRACTILITY; HUMAN; IMMUNE RESPONSE; NEWBORN DISEASE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SJOEGREN SYNDROME; ANIMAL; FLUORESCENT ANTIBODY TECHNIQUE; HEART ATRIUM; HEART BLOCK; IMMUNOLOGY; NEWBORN; PATHOPHYSIOLOGY; PHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATION; RAT;

ADULT; ANIMALS; ANIMALS, NEWBORN; AUTOANTIBODIES; CYCLIC GMP; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HEART ATRIA; HEART BLOCK; HUMANS; IMMUNOGLOBULIN G; INFANT, NEWBORN; INOSITOL PHOSPHATES; NITRIC OXIDE SYNTHASE; PREGNANCY; PREGNANCY COMPLICATIONS; RATS; RECEPTORS, MUSCARINIC; SJOGREN'S SYNDROME;

EID: 0033160529     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(99)00041-8     Document Type: Article

References (39)

1. Fax R.I., Robinson C.A., Curd J.G., Kozin F., Howell F.V. Sjögren's syndrome: proposed criteria for classification. Arthritis Rheum. 29:1986;577-585.
2. Pflugfelder S.C., Whitcher J.P., Daniels T.E. Sjögren's syndrome. Pepose J.S., Holland G.N., Wilhelmus K.R. Ocular infection and immunity. 1996;313-333 Mosby-Year Book, Saint Louis, MO.
3. Markusse H., Otten H., Vroom T., Smeets T., Fokkens N., Breeddveld F. Rheumatoid factor isotypes in serum and salivary fluid of patients with primary Sjögren's syndrome. Clin Immunol Immunopathol. 66:1993;26-32.
4. Block K.J., Buchanan W.W., Wohl M.J., Bunin J.J. Sjögren's syndrome: clinical pathological and serological studies of sixty-two cases. Medicine. 44:1965;187-231.
5. Moutsopoulos H.M., Chused T.M., Mann D.L. Sjögren's syndrome (sicca syndrome): current issues. Ann Intern Med. 92:1980;212-226.
6. Talal N. Recent development in immunology of Sjögren's syndrome (autoimmune exocrinopathy). Scand J Rheumatol. 61:1986;76-82.
7. Atkinson J.C., Fox P.C., Travis W.D. IgA rheumatoid factor and IgA containing immune complexes in primary Sjögren's syndrome. J Rheumatol. 16:1989;1205-1210.
8. Bendaoud B., Pennec Y.L., Lelong A. IgA-containing immune complexes in the circulation of patients with primary Sjögren's syndrome. J Autoimmun. 4:1991;177-184.
9. Bacman S., Sterin-Borda L., Camusso J.J., Arana R., Hubscher O., Borda E. Circulating antibodies against rat parotid gland M3 muscarinic receptors in primary Sjögren's syndrome. Clin Exp Immunol. 104:1996;454-459.
10. Bacman S., Perez Leiros C., Sterin-Borda L., Hubscher O., Arana R., Borda E. Autoantibodies against lacrimal gland M3 muscarinic acetylcholine receptors in patients with primary Sjögren's syndrome. Invest Ophthalmol Vis Sci. 39:1998;151-156.
11. Borda E., Camusso J.J., Perez Leiros C., Bacman S., Hubscher O., Arana R., Sterin-Borda L. Circulating antibodies against neonatal cardiac muscarinic acetylcholine receptor in patients with Sjögren's syndrome. Mol Cell Biochem. 163-164:1996;335-341.
12. Bacman S., Sterin-Borda L., Camusso J.J., Hubscher O., Arana R., Borda E. Circulating antibodies against neurotransmitter receptor activities in children with congenital heart block and their mothers. FASEB J. 8:1994;1170-1176.
13. Kausman D., Allen M., Snaith M.L., Isenberg D.A. Autoimmunity and the clinical spectrum of Sjögren's syndrome. Isenberg D., Horsfall A. Autoimmune diseases: focus on Sjögren's syndrome. 1994;1-20 Bios Scientific Publishers, Oxford, UK.
14. Provost T.T., Talal N., Harley J.B., Reichlin M., Alexander E.L. Relationship between anti-Ro(SS-A) antibody positive Sjögren's syndrome and antibody positive lupus erythematosus. Arch Dermatol. 124:1988;63-71.
15. Alexander E.L., McNicholl J., Watson R.M., Biaqs W.B., Reichlin M., Provost T.T. The immunogenetic relationship between anti Ro (SS-A)/La (SS-B) antibody positive Sjögren's syndrome and the neonatal lupus syndrome. J Invest Dermatol. 93:1989;751-756.
16. Buyon J.P., Tseng C.E., Di Donato F., Rahbaum W., Morris A., Chan E.K. Cardiac expression of 52 beta, an alternative transcript of the congenital heart block-associated 52 kd SS-A/Ro autoantigen, is maximal during fetal development. Arthritis Rheum. 40:1997;655-660.
17. Alexander E., Buyon J.P., Provost T.T., Guarnieri T. Anti Ro/SS-A antibodies in the pathophysiology of congenital heart block in neonatal lupus syndrome, an experimental model. Arthritis Rheum. 35:1992;176-189.
18. Boutjdir M., Chen L., Zhang Z.H., Tseng C.E., Di Donato F., Rashbaum W., Morris A., El Sherif N., Buyon J.P. Arrhythmogenicity of IgG and anti 52 kd SS-A/Ro affinity-purified antibodies from mothers of children with congenital heart block. Circ Res. 80:1997;354-362.
19. Sterin-Borda L., Genaro A.M., Perez Leiros C., Cremaschi G., Vila Echagüe A., Borda E. Role of nitric oxide in cardiac beta adrenoceptor inotropic response. Cell Signal. 10:1998;253-257.
20. Fu L., Magnunson Y., Berger C., Liljeovist A., Waagstein F., Hjalmarson A., Hoebeke J. Localization of functional autoimmune epitopes on the second extracellular loop of human muscarinic receptor m2 in patients with idiopathic dilated cardiomyopathy. J Clin Invest. 91:1993;1964-1968.
21. Goin J.C., Perez Leiros C., Borda E., Sterin-Borda L. Interaction of human chagasic IgG with the second extracellular loop of the human heart muscarinic acetylcholine receptor, functional and pathological implications. FASEB J. 10:1997;77-83.
22. Vitali C., Bombardieri S., Moutsopoulos H.M. Preliminary criteria for the classification of Sjögren's syndrome. Arthritis Rheum. 36:1993;340-347.
23. Berridge M.J. Inositol triphosphate and diacylgylcerol: a second messenger. Biochem J. 220:1984;345-360.
24. Cremaschi G., Sterin-Borda L. Stimulation of phosphoinositide hydrolysis via class I antigen-specific recognition in murine cardiac tissue. FEBS Lett. 249:1989;302-306.
25. Sterin-Borda L., Vila Echagüe A., Perez Leiros C., Genaro A.M., Borda E. Endogenous nitric oxide signalling system and the cardiac muscarinic acetylcholine receptor-inotropic response. Br J Pharmacol. 115:1995;1525-1531.
26. Watson R.M., Lane A.T., Barnett N.K., Bias W.B., Arnett F.C., Provost T.T. Neonatal lupus erythematosus: a clinical, serology and immunogenetic study with review of the literature. Medicine. 63:1984;362-378.
27. Flemming J.W., Wisler P.L., Watanabe A.M. Signal transduction by G proteins in cardiac tissue. Circulation. 85:1992;420-436.
28. Rosen M.R., Steinberg S.F., Danilo P. Jr. Developmental changes in the muscarinic stimulation of canine Purkinje fibers. J Pharmacol Exp Ther. 254:1990;356-361.
29. Sun L.S., Vulliemoz Y., Huber F., Bilezikian M., Robinson R.B. An excitatory muscarinic response in neonatal rat ventricular myocytes and its modulation by sympathetic innervation. J Mol Cell Cardiol. 26:1994;779-787.
30. Borda E., Perez Leiros C., Camusso J.J., Bacman S., Sterin-Borda L. Differential cholinoceptor subtype-dependent activation of signal transduction pathways in neonatal versus adult rat atria. Biochem Pharmacol. 53:1996;959-967.
31. Longabaugh J.P., Vatner D.E., Vatner S.F., Homcy C.J. Decreased stimulatory guanosine triphosphate binding protein in dogs with pressure-overload left ventricular failure. J Clin Invest. 81:1988;420-424.
32. Feldman A.M., Cates A.E., Veazey W.B., Hershberger R.E., Bristow M.R., Baughman K.L., Baumgartner W.A., Van Dop C. Increase of the 40.000 mol weight toxin substrate (G protein) in the failing human heart. J Clin Invest. 82:1988;189-197.
33. Morris S.A., Tanowitz H., Factor S.M., Bilezikian J.P., Wittner M. Myocardial adenylate cyclase activity in acute murine Chagas's disease. Circ Res. 62:1988;800-810.
34. Kessler P.D., Cates A.E., Van Dop C., Feldman A.M. Altered G protein function in cardiomyopathic Syrian hamster (Abstract). Circulation. 78:1988;560.
35. Tonwall J., Konttinen Y., Tuomen R., Tomwall M. Salivary gland acinar epithelial cells are deficient in their protein kinase C expression in Sjögren's syndrome. Lancet. 349:1997;1814-1819.
36. Yamamoto H., Sims N.E., Macauley S.P., Nguyen K.H., Nakagawa Y., Humphreys-Beher M.G. Alterations in the secretory response of nonobese diabetic (NOD) mice to muscarinic receptor stimulation. Clin Immunol Immunopathol. 78:1996;245-255.
37. Sterin-Borda L., Perez Leiros C., Goin J.C., Cremaschi G.A., Genaro A.M., Vila Echagüe A., Borda E. Participation of nitric oxide signaling system in the cardiac muscarinic cholinergic effect of human chagasic IgG. J Mol Cell Cardiol. 29:1997;1851-1865.
38. Silverman E.D. Congenital heart block and neonatal lupus erythematosus: prevention is the goal. J Rheumatol. 20:1993;1101-1104.
39. Buyon J.P., Ben-Chetrit E., Karp S. Acquired congenital heart block. Pattern of maternal antibody response to biochemically defined antigens of the SS-A/Ro-SS-B/La system in neonatal lupus. J Clin Invest. 84:1989;627-634.